Multidisciplinary Collaboration and Current Approaches in the Treatment of Uveitis
Özet
Referanslar
Ghadiri N, Reekie IR, Gordon I, et al. Systematic review of clinical practice guidelines for uveitis. BMJ Open Ophthalmol. 2023 Jan;8(1):e001091. doi: 10.1136/bmjophth-2022-001091.
Heiligenhaus A, Rothaus K, Pleyer U. Entwicklung von Klassifikationskriterien für Uveitiden von der Standardization of Uveitis Nomenclature (SUN) Working Group [Development of classification criteria for uveitis by the standardization of uveitis nomenclature (SUN) working group]. Ophthalmologe. 2021 Sep;118(9):913-918. German. doi: 10.1007/s00347-021-01486-2.
Kirupaharan N, Marshall RF, Spangler MD, et al. Incidence and Prevalence of Uveitis and Associated Ocular Complications in the United States TriNetX Database. Am J Ophthalmol. 2025 Aug;276:30-39. doi: 10.1016/j.ajo.2025.03.032.
Wakefield D, Chang JH. Epidemiology of uveitis. Int Ophthalmol Clin. 2005 Spring;45(2):1-13. doi: 10.1097/01.iio.0000155938.83083.94.
Ferreira LB, Smith AJ, Smith JR. Biologic Drugs for the Treatment of Noninfectious Uveitis. Asia Pac J Ophthalmol (Phila). 2021 Jan 19;10(1):63-73. doi: 10.1097/APO.0000000000000371.
Jabs DA. Improving the reporting of clinical case series. Am J Ophthalmol. 2005 May;139(5):900-5. doi: 10.1016/j.ajo.2004.12.009.
Rosenbaum JT and Dick AD. (2018), The Eyes Have it. Arthritis Rheumatol, 70: 1533-1543. https://doi.org/10.1002/art.40568.
Sun L, Wu R, Xue Q, et al. Risk factors of uveitis in ankylosing spondylitis: An observational study. Medicine (Baltimore). 2016 Jul;95(28):e4233. doi: 10.1097/MD.0000000000004233.
Hatemi G, Uçar D, Uygunoğlu U, Yazici H, Yazici Y. Behçet Syndrome. Rheum Dis Clin North Am. 2023 Aug;49(3):585-602. doi: 10.1016/j.rdc.2023.03.010.
Angeles-Han ST, Srivastava SK. Screening, Monitoring, and Treating Children With Juvenile Idiopathic Arthritis-associated Uveitis: Visualizing Better Outcomes. J Rheumatol. 2023 Mar;50(3):300-303. doi: 10.3899/jrheum.221092.
Gupta A, Sharma A, Bansal R, et al. Classification of intraocular tuberculosis. Ocul Immunol Inflamm. 2015 Feb;23(1):7-13. doi: 10.3109/09273948.2014.967358.
Cunningham ET, Eandi CM, Pichi F. Syphilitic uveitis. Ocul Immunol Inflamm. 2014 Feb;22(1):2-3. doi: 10.3109/09273948.2014.883236.
Miyagaki M, Zong Y, Yang M, Zhang J, Zou Y, Ohno-Matsui K, Kamoi K. Ocular Toxoplasmosis: Advances in Toxoplasma gondii Biology, Clinical Manifestations, Diagnostics, and Therapy. Pathogens. 2024; 13(10):898. https://doi.org/10.3390/pathogens13100898.
Burrow W, Ceniza A, Kan B, et al. Multiple Sclerosis-Associated Uveitis Therapy: Is Modern Better than Old Reliable? Journal of Clinical & Translational Ophthalmology. 2025; 3(4):22. https://doi.org/10.3390/jcto3040022.
Lo TC, Chen YY & Chen HH. Risk of inflammatory bowel disease in uveitis patients: a population-based cohort study. Eye 36, 1288–1293 (2022). https://doi.org/10.1038/s41433-021-01645-4.
Belletti M, Izquierdo-Escamez R, Tornero C, et al. Safe Use of Corticosteroids in Non-Infectious Uveitis. J Inflamm Res. 2025 Oct 17;18:14441-14455. doi: 10.2147/JIR.S540821.
Mérida S, Palacios E, Navea A, et al. New Immunosuppressive Therapies in Uveitis Treatment. International Journal of Molecular Sciences. 2015; 16(8):18778-18795. https://doi.org/10.3390/ijms160818778.
Nguyen QD, Merrill PT, Jaffe GJ, et al. Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Lancet. 2016 Sep 17;388(10050):1183-92. doi: 10.1016/S0140-6736(16)31339-3. Epub 2016 Aug 16. Erratum in: Lancet. 2016 Sep 17;388(10050):1160. doi: 10.1016/S0140-6736(16)31538-0.
Hatemi G, Christensen R, Bang D, et al. 2018 update of the EULAR recommendations for the management of Behçet's syndrome. Ann Rheum Dis. 2018 Jun;77(6):808-818. doi: 10.1136/annrheumdis-2018-213225.
Stavrakas P, Christou EE, Nasikas V, et al. Efficacy of Intravitreal Dexamethasone Implant (Ozurdex®) in Naïve and Refractory Patients with Different Morphological Subtypes of Diabetic Macular Edema. Medicina. 2025; 61(3):488. https://doi.org/10.3390/medicina61030488.
Fonollosa A, Carreño E, Agarwal A. Editorial: Multimodal imaging in uveitis. Front Med (Lausanne). 2022 Sep 2;9:1011628. doi: 10.3389/fmed.2022.1011628.
Referanslar
Ghadiri N, Reekie IR, Gordon I, et al. Systematic review of clinical practice guidelines for uveitis. BMJ Open Ophthalmol. 2023 Jan;8(1):e001091. doi: 10.1136/bmjophth-2022-001091.
Heiligenhaus A, Rothaus K, Pleyer U. Entwicklung von Klassifikationskriterien für Uveitiden von der Standardization of Uveitis Nomenclature (SUN) Working Group [Development of classification criteria for uveitis by the standardization of uveitis nomenclature (SUN) working group]. Ophthalmologe. 2021 Sep;118(9):913-918. German. doi: 10.1007/s00347-021-01486-2.
Kirupaharan N, Marshall RF, Spangler MD, et al. Incidence and Prevalence of Uveitis and Associated Ocular Complications in the United States TriNetX Database. Am J Ophthalmol. 2025 Aug;276:30-39. doi: 10.1016/j.ajo.2025.03.032.
Wakefield D, Chang JH. Epidemiology of uveitis. Int Ophthalmol Clin. 2005 Spring;45(2):1-13. doi: 10.1097/01.iio.0000155938.83083.94.
Ferreira LB, Smith AJ, Smith JR. Biologic Drugs for the Treatment of Noninfectious Uveitis. Asia Pac J Ophthalmol (Phila). 2021 Jan 19;10(1):63-73. doi: 10.1097/APO.0000000000000371.
Jabs DA. Improving the reporting of clinical case series. Am J Ophthalmol. 2005 May;139(5):900-5. doi: 10.1016/j.ajo.2004.12.009.
Rosenbaum JT and Dick AD. (2018), The Eyes Have it. Arthritis Rheumatol, 70: 1533-1543. https://doi.org/10.1002/art.40568.
Sun L, Wu R, Xue Q, et al. Risk factors of uveitis in ankylosing spondylitis: An observational study. Medicine (Baltimore). 2016 Jul;95(28):e4233. doi: 10.1097/MD.0000000000004233.
Hatemi G, Uçar D, Uygunoğlu U, Yazici H, Yazici Y. Behçet Syndrome. Rheum Dis Clin North Am. 2023 Aug;49(3):585-602. doi: 10.1016/j.rdc.2023.03.010.
Angeles-Han ST, Srivastava SK. Screening, Monitoring, and Treating Children With Juvenile Idiopathic Arthritis-associated Uveitis: Visualizing Better Outcomes. J Rheumatol. 2023 Mar;50(3):300-303. doi: 10.3899/jrheum.221092.
Gupta A, Sharma A, Bansal R, et al. Classification of intraocular tuberculosis. Ocul Immunol Inflamm. 2015 Feb;23(1):7-13. doi: 10.3109/09273948.2014.967358.
Cunningham ET, Eandi CM, Pichi F. Syphilitic uveitis. Ocul Immunol Inflamm. 2014 Feb;22(1):2-3. doi: 10.3109/09273948.2014.883236.
Miyagaki M, Zong Y, Yang M, Zhang J, Zou Y, Ohno-Matsui K, Kamoi K. Ocular Toxoplasmosis: Advances in Toxoplasma gondii Biology, Clinical Manifestations, Diagnostics, and Therapy. Pathogens. 2024; 13(10):898. https://doi.org/10.3390/pathogens13100898.
Burrow W, Ceniza A, Kan B, et al. Multiple Sclerosis-Associated Uveitis Therapy: Is Modern Better than Old Reliable? Journal of Clinical & Translational Ophthalmology. 2025; 3(4):22. https://doi.org/10.3390/jcto3040022.
Lo TC, Chen YY & Chen HH. Risk of inflammatory bowel disease in uveitis patients: a population-based cohort study. Eye 36, 1288–1293 (2022). https://doi.org/10.1038/s41433-021-01645-4.
Belletti M, Izquierdo-Escamez R, Tornero C, et al. Safe Use of Corticosteroids in Non-Infectious Uveitis. J Inflamm Res. 2025 Oct 17;18:14441-14455. doi: 10.2147/JIR.S540821.
Mérida S, Palacios E, Navea A, et al. New Immunosuppressive Therapies in Uveitis Treatment. International Journal of Molecular Sciences. 2015; 16(8):18778-18795. https://doi.org/10.3390/ijms160818778.
Nguyen QD, Merrill PT, Jaffe GJ, et al. Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Lancet. 2016 Sep 17;388(10050):1183-92. doi: 10.1016/S0140-6736(16)31339-3. Epub 2016 Aug 16. Erratum in: Lancet. 2016 Sep 17;388(10050):1160. doi: 10.1016/S0140-6736(16)31538-0.
Hatemi G, Christensen R, Bang D, et al. 2018 update of the EULAR recommendations for the management of Behçet's syndrome. Ann Rheum Dis. 2018 Jun;77(6):808-818. doi: 10.1136/annrheumdis-2018-213225.
Stavrakas P, Christou EE, Nasikas V, et al. Efficacy of Intravitreal Dexamethasone Implant (Ozurdex®) in Naïve and Refractory Patients with Different Morphological Subtypes of Diabetic Macular Edema. Medicina. 2025; 61(3):488. https://doi.org/10.3390/medicina61030488.
Fonollosa A, Carreño E, Agarwal A. Editorial: Multimodal imaging in uveitis. Front Med (Lausanne). 2022 Sep 2;9:1011628. doi: 10.3389/fmed.2022.1011628.
